Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Gains from Investment Securities (2018 - 2025)

Neurogene's Gains from Investment Securities history spans 6 years, with the latest figure at $61000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 535.71% year-over-year to $61000.0; the TTM value through Dec 2025 reached $61000.0, up 144.0%, while the annual FY2025 figure was $61000.0, 144.0% up from the prior year.
  • Gains from Investment Securities reached $61000.0 in Q4 2025 per NGNE's latest filing, up from -$14000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $200000.0 in Q2 2023 to a low of -$35000.0 in Q2 2024.
  • Average Gains from Investment Securities over 3 years is $34333.3, with a median of $10000.0 recorded in 2023.
  • The largest YoY upside for Gains from Investment Securities was 1100.0% in 2024 against a maximum downside of 275.0% in 2024.
  • A 3-year view of Gains from Investment Securities shows it stood at $8000.0 in 2023, then plummeted by 275.0% to -$14000.0 in 2024, then surged by 535.71% to $61000.0 in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Gains from Investment Securities are $61000.0 (Q4 2025), -$14000.0 (Q4 2024), and $14000.0 (Q3 2024).